mitoxantrone has been researched along with Demyelinating Diseases in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doshi, A | 1 |
| Chataway, J | 1 |
| Jaster, JH | 1 |
| Niell, HB | 1 |
| Dohan, FC | 1 |
| Smith, TW | 1 |
| Tourbah, A | 1 |
| Stievenart, JL | 1 |
| Edan, G | 1 |
| Abanou, A | 1 |
| Dormont, D | 1 |
| Lyon-Caen, O | 1 |
1 review available for mitoxantrone and Demyelinating Diseases
| Article | Year |
|---|---|
Multiple sclerosis, a treatable disease .
Topics: Adjuvants, Immunologic; Alemtuzumab; Crotonates; Demyelinating Diseases; Dimethyl Fumarate; Fingolim | 2017 |
2 other studies available for mitoxantrone and Demyelinating Diseases
| Article | Year |
|---|---|
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Topics: Adult; Antineoplastic Agents; Carcinoma; Cohort Studies; Colonic Neoplasms; Demyelinating Diseases; | 2003 |
Acute demyelination: an insight into the effect of mitoxantrone on CNS lesions.
Topics: Acute Disease; Adult; Brain Diseases; Demyelinating Diseases; Female; Humans; Magnetic Resonance Ima | 2005 |